TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
STOK

Stoke Therapeutics Inc

Healthcare · Biotechnology

28.40$ -1.7% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Stoke Therapeutics Inc (STOK): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/03/2026.

Next report 11/03/2026
Last report 08/03/2026
Earnings surprise by quarter (%)
Q3 23 · 14.1 % 23 Q4 23 · 4.8 % 23 Q1 24 · 6.6 % 24 Q2 24 · 17.9 % 24 Q3 24 · 13.0 % 24 Q4 24 · 66.1 % 24 Q1 25 · 2,211.1 % 25 Q2 25 · 25.9 % 25 Q3 25 · -14.0 % 25 Q4 25 · -36.0 % 25 Q1 26 · 3.7 % 26 Q2 26 · -13.4 % 26

EPS estimate beaten

Full history 18 of 30 quarters (60%)
Last 16 quarters 12 of 16 quarters (75%)

Earnings Call Transcripts

Search all transcripts →

  • 08/03/2026 Earnings Call Q2 2026 Open →

News on This Stock

  • 08/03/2026 Stoke Therapeutics, Inc. (STOK): Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/03/2026 Stoke Therapeutics, Inc. (STOK): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?